LTF and cancer: Some proteins, e.g., transferrin and lactoferrin, can be specifically bound to receptor(s) highly expressed in considerable cancer cells via receptor-ligand interaction, enabling the construction of active targeted theranostic nanoplatforms (Kanwar et al., 2016; Wang et al., 2016a, 2017a).